{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T20:31:14Z","timestamp":1787776274682,"version":"build-2784847793"},"reference-count":21,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2017,1]]},"abstract":"<jats:sec>\n                    <jats:title>Objective:<\/jats:title>\n                    <jats:p>In this study, frequency and antimicrobial sensitivity pattern of multidrug resistant (MDR) microorganisms were evaluated in a referral teaching hospital in Iran.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>Patients with MDR Gram-negative pathogens were followed during the course of hospitalization. Demographic data, baseline diseases, type of biological sample, isolated microorganism, type of infection, antibiotic regimen before the availability of the culture result and change in the antibiotic regimen following receiving the antibiogram results, response to the treatment regimen, and duration of hospitalization and patient's outcome were considered variables for each recruited patient.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Findings:<\/jats:title>\n                    <jats:p>\n                      In 71% of the patients, antibiotic regimens were changed according to the antibiogram results. A carbapenem alone or plus amikacin or ciprofloxacin were selected regimens for patients with extended-spectrum beta-lactamase (ESBL) infections. For patients with probable carbapenem-resistant\n                      <jats:italic toggle=\"yes\">Enterobacteriaceae<\/jats:italic>\n                      infections, a carbapenem plus colistin was the most common antibiotic regimen. Clinical response was detected in 54.5% of the patients who were treated based on the antibiogram results. Clinical response was higher in the ESBL producers (ESBL-P) than the non-ESBL-P infections (75% vs. 52%). However, this difference was not significant (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.09). Most nonresponders (80%) had sepsis due to\n                      <jats:italic toggle=\"yes\">Klebsiella<\/jats:italic>\n                      species. Finally, 41.9% of the patients were discharged from the hospital and 58.2% died.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Same as other countries, infections due MDR microorganisms is increasing in the recent years. This type of resistance caused poor clinical response and high rate mortality in the patients.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/2279-042x.200990","type":"journal-article","created":{"date-parts":[[2017,3,7]],"date-time":"2017-03-07T07:48:38Z","timestamp":1488872918000},"page":"44-51","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Clinical Response and Outcome in Patients with Multidrug Resistant Gram-negative Infections"],"prefix":"10.4103","volume":"6","author":[{"given":"Masoume","family":"Malekolkottab","sequence":"first","affiliation":[{"name":"Department of Clinical Pharmacy, Tehran University of Medical Sciences, Tehran, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lida","family":"Shojaei","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacy, Tehran University of Medical Sciences, Tehran, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hossein","family":"Khalili","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacy, Tehran University of Medical Sciences, Tehran, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahsa","family":"Doomanlou","sequence":"additional","affiliation":[{"name":"Central Laboratory, Imam Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20250523","first-page":"277","article-title":"The antibiotic resistance crisis: Part 1: Causes and threats","volume":"40","author":"Ventola","year":"2015","journal-title":"P T"},{"key":"R2-20250523","first-page":"30","article-title":"The state of the world's antibiotics 2015","volume":"8","author":"Gelbrand","year":"2015","journal-title":"Wound Heal South Afr"},{"key":"R3-20250523","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.medmal.2015.03.003","article-title":"Non-carbapenem therapy of urinary tract infections caused by extended-spectrum \u00df-lactamase-producing Enterobacteriaceae","volume":"45","author":"de La Blanchardi\u00e8re","year":"2015","journal-title":"Med Mal Infect"},{"key":"R4-20250523","first-page":"741","article-title":"Frequency of extended spectrum beta lactamase producing Enterobacteriaceae among urinary pathogen isolates","volume":"21","author":"Afridi","year":"2011","journal-title":"J Coll Physicians Surg Pak"},{"key":"R6-20250523","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s13613-015-0061-0","article-title":"Mechanisms of antimicrobial resistance in gram-negative bacilli","volume":"5","author":"Rupp\u00e9","year":"2015","journal-title":"Ann Intensive Care"},{"key":"R7-20250523","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1128\/CMR.18.4.657-686.2005","article-title":"Extended-spectrum beta-lactamases: A clinical update","volume":"18","author":"Paterson","year":"2005","journal-title":"Clin Microbiol Rev"},{"key":"R8-20250523","first-page":"162","article-title":"High prevalence of multidrug resistance and metallo-beta-lactamase (M\u00dfL) producing Acinetobacter baumannii isolated from patients in ICU wards, Hamadan, Iran","volume":"13","author":"Safari","year":"2013","journal-title":"J Res Health Sci"},{"key":"R9-20250523","first-page":"881","article-title":"Frequency of extended spectrum beta-lactamase (ESBLs) producing Escherichia coli and Klebseilla pneumonia isolated from urine in an Iranian 1000-bed tertiary care hospital","volume":"4","author":"Behrooozi","year":"2010","journal-title":"Afr J Microbiol Res"},{"key":"R11-20250523","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/0196-6553(88)90053-3","article-title":"CDC definitions for nosocomial infections, 1988","volume":"16","author":"Garner","year":"1988","journal-title":"Am J Infect Control"},{"key":"R12-20250523","first-page":"101","article-title":"Prevalence of multiple drug resistant clinical isolates of extended-spectrum beta-lactamase producing Enterobacteriaceae in Southeast Iran","volume":"35","author":"Mansouri","year":"2015","journal-title":"Iran J Med Sci"},{"key":"R13-20250523","first-page":"169","article-title":"Prevalence of extended spectrum \u03b2-lactamase-producing Enterobacteriaceae by phenotypic and genotypic methods in intensive care units in Tehran, Iran","volume":"16","author":"Mirsalehian","year":"2008","journal-title":"Daru"},{"key":"R14-20250523","doi-asserted-by":"crossref","first-page":"3420","DOI":"10.1128\/JCM.01314-09","article-title":"Use of boronic acid disk tests to detect extended- spectrum beta-lactamases in clinical isolates of KPC carbapenemase-possessing enterobacteriaceae","volume":"47","author":"Tsakris","year":"2009","journal-title":"J Clin Microbiol"},{"key":"R15-20250523","doi-asserted-by":"crossref","first-page":"91","DOI":"10.2174\/1874285801105010091","article-title":"The prevalence of ESBLs producing Klebsiella pneumoniae isolates in some major hospitals, Iran","volume":"5","author":"Ghafourian","year":"2011","journal-title":"Open Microbiol J"},{"key":"R16-20250523","first-page":"42","article-title":"Prevalence of ESBL and MBL in Acinetobacter baumanii isolated from Iranian patients during the recent 10 years","volume":"43","author":"Hasanvand","year":"2014","journal-title":"Iran J Public Health"},{"key":"R17-20250523","doi-asserted-by":"crossref","first-page":"611","DOI":"10.2298\/ABS140506021F","article-title":"Antibiotic susceptibility patterns of isolated bacteria from bile fluids of patients with gallstone disease in Isfahan city (Iran)","volume":"67","author":"Fatemi","year":"2015","journal-title":"Arch Biol Sci"},{"key":"R18-20250523","doi-asserted-by":"crossref","first-page":"12","DOI":"10.3329\/pulse.v6i1-2.20328","article-title":"Comparison of three dimensional test and double disc synergy test for detection of extended spectrum \u03b2-lactamase (ESBL) producing gram negative bacteria","volume":"6","author":"Biswas","year":"2014","journal-title":"Pulse"},{"key":"R19-20250523","doi-asserted-by":"crossref","first-page":"2997","DOI":"10.1128\/jcm.34.12.2997-3001.1996","article-title":"Detection of extended-spectrum-beta-lactamase-producing members of the family Enterobacteriaceae with Vitek ESBL test","volume":"34","author":"Sanders","year":"1996","journal-title":"J Clin Microbiol"},{"key":"R20-20250523","doi-asserted-by":"crossref","first-page":"15","DOI":"10.5644\/ama2006-124.66","article-title":"Comparison of double disk synergy test, VITEK 2 and Check-MDR CT102 for detection of ESBL producing isolates","volume":"42","author":"Numanovic","year":"2013","journal-title":"Acta Med Acad"},{"key":"R21-20250523","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1128\/JCM.03614-13","article-title":"Rapid detection of \u00df-lactamase-hydrolyzing extended-spectrum cephalosporins in Enterobacteriaceae by use of the new chromogenic \u00dfLacta test","volume":"52","author":"Morosini","year":"2014","journal-title":"J Clin Microbiol"},{"key":"R22-20250523","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1128\/JCM.03361-13","article-title":"Modified CLSI extended-spectrum \u00df-lactamase (ESBL) confirmatory test for phenotypic detection of ESBLs among Enterobacteriaceae producing various \u00df-lactamases","volume":"52","author":"Poulou","year":"2014","journal-title":"J Clin Microbiol"},{"key":"R23-20250523","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1086\/380645","article-title":"Bacteremia due to Klebsiella pneumoniae isolates producing the TEM-52 extended-spectrum beta-lactamase: Treatment outcome of patients receiving imipenem or ciprofloxacin","volume":"38","author":"Endimiani","year":"2004","journal-title":"Clin Infect Dis"}],"container-title":["Journal of Research in Pharmacy Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/01730163-201706010-00009","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T20:04:53Z","timestamp":1787774693000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/01730163-201706010-00009"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.4103\/2279-042x.200990","relation":{},"ISSN":["2319-9644","2279-042X"],"issn-type":[{"value":"2319-9644","type":"print"},{"value":"2279-042X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,1]]},"assertion":[{"value":"2016-03-01","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2016-05-01","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}